sc13gza
 

     
 
OMB APPROVAL
  
 
OMB Number: 3235-0145
  
 
Expires: February 28, 2006
  
 
Estimated average burden hours per response...11
  
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

Bentley Pharamaceuticals
(Name of Issuer)
Common Stock
(Title of Class of Securities)
082657107
(CUSIP Number)
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     o Rule 13d-1(c)

     o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 
 

 

                     
CUSIP No.
  
082657107 
   Page  
2 
   of   
4 Pages 

 

           
1   NAMES OF REPORTING PERSONS:
Luther King Capital Management Corporation
301 Commerce Street, Suite 1600
Fort Worth, TX 76102
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
    75-0163033
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
  Shares are also owned in accounts for the benefit of Luther King Capital                   (a)   o
  Management employees                                                                                               (b)   þ
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  Fort Worth, Texas
       
  5   SOLE VOTING POWER:
     
NUMBER OF   1,161,800 Luther King Capital Management
      2,000 Jim Kerrigan
      3,000 Alan Marshall
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY  
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   1,161,800 Luther King Capital Management
      2,000 Jim Kerrigan
      3,000 Alan Marshall
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
   
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  1,166,800
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  5.3%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  IA

 

                     
CUSIP No.
  
082657107 
   Page  
3 
   of   
4 Pages 
         
Item 1.
  (a)   Name of Issuer:
 
      Bentley Pharmaceuticals
 
        
 
  (b)   Address of Issuer’s Principal Executive Offices:
 
      2 Holland Way, Bentley Park
 
      Exeter, NH 03833
 
        
Item 2.
  (a)   Name of Person Filing:
 
      Luther King Capital Management Corporation
 
        
 
  (b)   Address of Principal Business Office, or if None, Residence:
 
      301 Commerce Street, Suite 1600
 
      Fort Worth, TX 76102
 
        
 
  (c)   Citizenship:
 
      Fort Worth, Texas USA
 
        
 
  (d)   Title of Class of Securities:
 
      Common Stock
 
        
 
  (e)   CUSIP Number:
 
      082657107 
 
        
Item 3.   Luther King is an Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940
 
        
Item 4.
  (a)   Amount Beneficially Owned:
 
      1,166,800 
 
        
 
  (b)   Percent of Class:
 
      5.3% 
 
        
 
  (c)   Number of shares as to which such person has:
(i)
  sole power to vote or to direct the vote
 
  1,166,800  
(ii)
  shared power to vote or to direct the vote
 
        
(iii)
  sole power to dispose or to direct the disposition of
 
  1,166,800  
(iv)
  shared power to dispose or to direct the disposition of
     
Item 5.
  Ownership of Five Percent or Less of a Class
 
    
 
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: o
 
    
Item 6.
  Ownership of More than Five Percent on Behalf of Another Person

 

 

                     
CUSIP No.
  
082657107 
   Page  
4 
   of   
4 Pages 
     
Item 7.
  Identification and Classification of the Subsidiary which Acquired the Security being Reported on by the Parent Holding Company
 
    
 
    
Item 8.
  Identification and Classification of Members of the Group
 
    
 
    
Item 9.
  Notice of Dissolution of Group
 
    
 
    
Item 10.
  Certification
 
    
 
  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.
 
    
 
  Signature
 
    
 
  After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
Date:
  February 9, 2006
 
    
Signature:
  /s/ J. Luther King, Jr.
 
   
 
    
Name/Title:
  President